AzTrials
AzTrials

DysphagiaEFFORT-PDNCT07773025

Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With PD

A study testing Effortful swallow in people with Dysphagia and Parkinson Disease (PD), run by University of Alberta.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether a 4-week effortful swallow exercise program helps adults with Parkinson disease who have swallowing problems. The effortful swallow is a swallowing exercise where a person swallows with extra effort. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dysphagia, Parkinson Disease (PD)
What is being tested?
Effortful swallow
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
No sites listed yet
Study dates
1 Jan 2027to 31 Aug 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Neurologist-confirmed diagnosis of Parkinson disease
  • Self-report of one or more swallowing symptoms, such as difficulty managing secretions, coughing during meals, choking on food, or respiratory infection other than COVID-19 in the past 6 months
  • Baseline videofluoroscopic swallowing assessment showing prolonged time to laryngeal vestibule closure and/or poor pharyngeal area at maximum constriction on regular-effort swallows with thin or mildly thick liquid stimuli, relative to healthy reference values

Who cannot join

  • History of head and neck cancer
  • History of radical neck dissection, anterior cervical spine surgery, or neck/oropharyngeal surgery, except tonsillectomy or adenoidectomy
  • History of any neurological disease other than Parkinson disease
  • Cognitive or receptive communication difficulties that preclude the ability to follow English-language study instructions
  • History of brain surgery, including deep brain stimulation

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Pooja Gandhi, PhD, R.SLP, SLP(C) contact

7804920596

pooja.gandhi@ualberta.ca

About this study

Official title: EFFORT-PD: Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With Parkinson Disease

The goal of this clinical trial is to learn whether a 4-week effortful swallow exercise program helps adults with Parkinson disease who have swallowing problems. The effortful swallow is a swallowing exercise where a person swallows with extra effort.

Researchers will compare adults who start the exercise program right away with adults who start the program after a 4-week waiting period. All participants who remain eligible will have the opportunity to receive the exercise program.

Participants will have swallowing assessments, including video X-ray swallowing tests called videofluoroscopy. They will also complete questionnaires and take part in a remotely supervised swallowing exercise program with a speech-language pathologist. Participants who remain eligible and take part in the exercise program will use a tongue pressure device during practice. The main study period lasts about 10 weeks. Participants will also complete brief follow-up questionnaires at 6 months and 12 months.

Read the detailed description

This is a single-centre, randomized delayed-intervention study of a structured effortful swallow exercise program for adults with Parkinson disease and dysphagia. The effortful swallow is a swallowing exercise in which a person swallows with extra effort. The study is designed to evaluate whether a 4-week remotely supervised effortful swallow program can improve swallowing function.

Participants who remain eligible after baseline assessment will be randomly assigned to start the intervention right away or after a 4-week waiting period. This delayed-intervention design allows all eligible participants to receive the exercise program while also allowing researchers to compare swallowing outcomes between groups during the first 4 weeks.

The intervention will be delivered remotely by a speech-language pathologist. Participants will practise effortful swallow exercises at home and will use a tongue pressure device during practice to support measurement and feedback. Swallowing function will be assessed using videofluoroscopy, which is a video X-ray swallowing test. Participants will also complete questionnaires about swallowing and related health outcomes during the study and follow-up period.

Being tested
Effortful swallow
Keywords
Dysphagia, Parkinson disease, effortful swallow
Medical subject headings
Deglutition Disorders, Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Effortful swallowBehavioural

    A 4-week remotely supervised swallowing exercise program delivered by a speech-language pathologist. Participants will practise effortful swallows at home using saliva and mildly thick liquids, according to study instructions. Participants will use a tongue pressure device during practice to support measurement and feedback. Participants may also complete home practice logs.

Study groups in NCT07773025
Study groupRoleWhat they receive
Immediate InterventionExperimentalParticipants assigned to this arm will begin the 4-week effortful swallow exercise program after baseline assessment. The program is delivered remotely by a speech-language pathologist. Participants will practise swallowing exercises at home and will use a tongue pressure device during practice. Participants will complete swallowing assessments and questionnaires during the study and follow-up period.
Receives: Behavioral: Effortful swallow
Delayed InterventionOtherParticipants assigned to this arm will wait about 4 weeks before beginning the 4-week effortful swallow exercise program. During the waiting period, participants will continue usual clinical care as recommended by their health care team. After the waiting period, participants will receive the same remotely delivered effortful swallow exercise program as the immediate intervention group, including use of a tongue pressure device during practice.
Receives: Behavioral: Effortful swallow

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of Participants With Improved Swallowing Function at Week 5

    Improved swallowing function will be defined using videofluoroscopic swallowing study findings. Participants will be classified as improved if they show improvement in Penetration-Aspiration Scale score and/or reduced pharyngeal residue at Week 5 compared with baseline. The primary comparison will be between the immediate intervention group and the delayed-intervention group at Week 5, before the delayed-intervention group begins the exercise program.

    Measured: Baseline to Week 5

Secondary outcomes (2)
  1. Proportion of Participants With Improved Swallowing Function or Physiology at Week 10

    Participants will be classified as improved if they show one or both of the following at Week 10 compared with baseline: shorter time to laryngeal vestibule closure in association with improvement in Penetration-Aspiration Scale score; and/or improved pharyngeal constriction in association with reduced pharyngeal residue. Pharyngeal constriction and residue will be measured from videofluoroscopy using pixel-based tracing normalized to cervical spine length.

    Measured: Baseline to Week 10

  2. Change in Munich Dysphagia Test-Parkinson Disease Score

    Participant-reported swallowing symptoms will be measured using the Munich Dysphagia Test-Parkinson Disease questionnaire. Lower overall scores indicate improvement. Change from baseline will be assessed at Week 5, Week 10, 6 months, and 12 months.

    Measured: Baseline to Week 5, Week 10, 6 months, and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2026
  2. Study start1 Jan 2027 (estimated)
  3. Primary completion31 Aug 2029 (estimated)
  4. Study completion31 Aug 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
74 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07773025
Sponsor's protocol ID
Pro00168314
Acronym
EFFORT-PD
Status last verified
Aug 2026
First submitted
14 Aug 2026
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared with other researchers. Results will be reported in aggregate form. The study includes sensitive clinical and videofluoroscopy-derived data, and the current consent and ethics approval do not include a plan for sharing de-identified individual participant data outside the approved study team.

Questions about this trial

What is this clinical trial studying?

A study testing Effortful swallow in people with Dysphagia and Parkinson Disease (PD), run by University of Alberta.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Pooja Gandhi, PhD, R.SLP, SLP(C) (7804920596, pooja.gandhi@ualberta.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of Participants With Improved Swallowing Function at Week 5 (time frame: Baseline to Week 5). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in